Cardiovascular Diseases: Innovations in Diagnosis and Management
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 26
Special Issue Editor
Special Issue Information
Dear Colleagues,
Various studies on the prognosis of myocardial infarction are currently underway. Among these, new directions are being rapidly established in guidelines across different regions.
① Improvement of prognostic prediction models: Recent studies are advancing the development of models that use patients’ specific biomarkers and genetic profiles to more accurately predict individual patient outcomes.
② Association with inflammation: Inflammation markers have been shown to play an important role in predicting the risk of myocardial infarction.
③ Optimization of treatment strategies: Drug therapies such as antiplatelet therapy and statins are known to reduce the risk of myocardial infarction, but recent studies are exploring ways to optimize these treatment strategies.
These topics reflect important research findings aimed at improving the prognosis of patients following myocardial infarction.
Additionally, new biomarkers have emerged as promising indicators for diagnosing myocardial infarction and predicting prognosis. Combining these markers with traditional indicators is expected to enhance risk assessment and optimize treatment strategies for patients.
Dr. Hisao Hara
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- myocardial infarction
- biomarker
- prognosis
- coronary risk
- residual risk
- prognosis prediction
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
